Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer

Genome-wide analysis using microarrays has revolutionized breast cancer (BC) research. A substantial body of evidence supports the clinical utility of the 21-gene assay (Oncotype DX) and 70-gene assay (MammaPrint) to predict BC recurrence and the magnitude of benefit from chemotherapy. However, ther...

Full description

Bibliographic Details

Published in:	Brazilian Journal of Medical and Biological Research
Main Authors:	M.C. Kneubil, K.O.B. Goulart, J. Brollo, G.P. Coelho, J. Mandelli, B.C. Orlandin, L.L. Corso, M. Roesch-Ely, J.A.P. Henriques
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2022-03-01
Subjects:	Breast cancer Neoadjuvant chemotherapy Expression of DNA repair genes
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100625&tlng=en